Is First Trust Innovation Leaders ETF halal to invest in?

As of September 2026, First Trust Innovation Leaders ETF ILDR is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is First Trust Innovation Leaders ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes First Trust Innovation Leaders ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for First Trust Innovation Leaders ETF updated?

The Shariah compliance status of First Trust Innovation Leaders ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like First Trust Innovation Leaders ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of First Trust Innovation Leaders ETF?

You can check the latest Shariah compliance status of First Trust Innovation Leaders ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

First Trust Innovation Leaders ETF ILDR

ILDR Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, First Trust Innovation Leaders ETF is classified as not halal.

NOT HALAL

Is First Trust Innovation Leaders ETF Halal?

Shariah Compliance Analysis of ILDR ETF

US Equity Theme

No. As of September 2026, First Trust Innovation Leaders ETF (ILDR) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. First Trust Innovation Leaders ETF does not pass Musaffa's business and financial screening criteria.

ILDR was created on 2021-05-25 by First Trust. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 218.79m in AUM and 85 holdings. ILDR is an actively managed fund that seeks capital appreciation by targeting global companies believed to benefit from scientific and technological innovation.

First Trust Innovation Leaders ETF (ILDR) Chart

Key Statistics of First Trust Innovation Leaders ETF (ILDR)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Information Technology
46.54%
Health Care
15.96%
Industrials
13.52%
Other
7.08%
Financials
5.99%
Consumer Discretionary
5.84%
Communication Services
5.07%

FAQ's for First Trust Innovation Leaders ETF (ILDR)

As of September 2026, First Trust Innovation Leaders ETF ILDR is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes First Trust Innovation Leaders ETF using these criteria to determine its compliance status.
The Shariah compliance status of First Trust Innovation Leaders ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of First Trust Innovation Leaders ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.